NO963780L - Direkte fluorescenskonjugert immunoassey for blodplateaktivering - Google Patents

Direkte fluorescenskonjugert immunoassey for blodplateaktivering

Info

Publication number
NO963780L
NO963780L NO963780A NO963780A NO963780L NO 963780 L NO963780 L NO 963780L NO 963780 A NO963780 A NO 963780A NO 963780 A NO963780 A NO 963780A NO 963780 L NO963780 L NO 963780L
Authority
NO
Norway
Prior art keywords
immunoassey
conjugated
platelet activation
direct fluorescence
degree
Prior art date
Application number
NO963780A
Other languages
English (en)
Other versions
NO963780D0 (no
Inventor
Bruce A Kottke
Original Assignee
Watson Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Watson Clinic Foundation filed Critical Watson Clinic Foundation
Publication of NO963780D0 publication Critical patent/NO963780D0/no
Publication of NO963780L publication Critical patent/NO963780L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G01N2333/70564—Selectins, e.g. CD62

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Det er fremlagt en fremgangsmåte til måling av graden av blodplateaktivering ved fluoremetrisk å bestemme graden av P-selectins ekspresjon i en prøve av fullblod in vitro, ved anvendelse av en maksimalt aktivert blodplateprøve som referanseverdi.
NO963780A 1994-10-25 1996-09-10 Direkte fluorescenskonjugert immunoassey for blodplateaktivering NO963780L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32847594A 1994-10-25 1994-10-25
US47098095A 1995-06-06 1995-06-06
PCT/US1995/014041 WO1996012956A1 (en) 1994-10-25 1995-10-24 Direct fluorescence-conjugated immunoassay for platelet activation

Publications (2)

Publication Number Publication Date
NO963780D0 NO963780D0 (no) 1996-09-10
NO963780L true NO963780L (no) 1997-08-25

Family

ID=26986392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963780A NO963780L (no) 1994-10-25 1996-09-10 Direkte fluorescenskonjugert immunoassey for blodplateaktivering

Country Status (7)

Country Link
JP (1) JPH10512951A (no)
AU (1) AU689346B2 (no)
BR (1) BR9507579A (no)
CA (1) CA2184826A1 (no)
FI (1) FI963848A (no)
NO (1) NO963780L (no)
WO (1) WO1996012956A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0946877A1 (en) * 1996-11-13 1999-10-06 Centocor, Inc. P-selectin assays and methods of use thereof
GB2338236B (en) 1998-06-13 2003-04-09 Aea Technology Plc Microbiological cell processing
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
JP2001131078A (ja) * 1999-11-09 2001-05-15 Iatron Lab Inc 新規活性固定化血小板及びその製造方法
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
US6913932B2 (en) * 2002-08-23 2005-07-05 Beckman Coulter, Inc. Formaldehyde-ammonium salt complexes for the stabilization of blood cells
EP2377947A4 (en) * 2008-12-18 2012-05-30 Sysmex Corp METHOD FOR DETECTING CANCER CELLS IN A BLOOD TEST
DK3054936T5 (da) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino) benzensulfonamid derivater som 12-lipoxygenase inhibitorer
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
FR3109999A1 (fr) * 2020-05-05 2021-11-12 Etablissement Français Du Sang Methode de detection de l’activation plaquettaire liee a l’inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783330A (en) * 1984-11-15 1988-11-08 New England Medical Center Hospitals, Inc. Monoclonal antibodies to activated platelets
US5030554A (en) * 1987-12-04 1991-07-09 Coulter Corporation Conservative whole blood sample preparation technique

Also Published As

Publication number Publication date
NO963780D0 (no) 1996-09-10
WO1996012956A1 (en) 1996-05-02
BR9507579A (pt) 1997-09-09
JPH10512951A (ja) 1998-12-08
FI963848A0 (fi) 1996-09-26
AU689346B2 (en) 1998-03-26
CA2184826A1 (en) 1996-05-02
MX9604205A (es) 1998-05-31
FI963848A (fi) 1996-09-26
AU4016895A (en) 1996-05-15

Similar Documents

Publication Publication Date Title
NO963780L (no) Direkte fluorescenskonjugert immunoassey for blodplateaktivering
NO891410D0 (no) Fremgangsmaate for undersoekelse av egenskapene til undergrunnsformasjoner som gjennomtrenges av et borehull.
KR910021234A (ko) 이리도이드 글리코시드 및 그 애글리콘에 의한 모발 염색 방법 및 이 방법에 사용되는 조성물
NO981586L (no) Kontrastmiddel for nµrinfrar÷d-diagnostikken, inneholdende systemer som er anriket med polymetinfarvestoffer
AR246253A1 (es) Procedimiento para obtener derivados de dideshidro-vitamina d3.
IE860077L (en) Glycosidic derivatives
NO974572L (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
NO910871L (no) Trykkdempningsapparat.
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
NO982874L (no) Farmasöytiske preparater med vitamin D-analoger
NO20003206L (no) Polyetoksylert ricinusolje, samt fremgangsmÕte til fremstilling av samme
ES2138212T3 (es) Derivado de la vitamina d3 y procedimiento para producirlo.
NO962063L (no) Fluorfenylsubstituerte alkenylkarboksylsyre-guanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikament inneholdende dem
NO305868B1 (no) Alginat-oligosakkarid, framgangsmÕte for framstilling av alginat-oligosakkarid i blodtrykksendende nµringsmiddel
NO962006D0 (no) Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem
NO870737D0 (no) Plaster til bruk ved proevetaking av blod.
NO963108D0 (no) Substituerte kanelsyreguanidider, fremgangsmåte for fremstilling, anvendelse som medikament eller diagnostikum som inneholder disse
NO960364D0 (no) Basisk-substituerte benzolguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
ATE162188T1 (de) Herstellung von derivaten von n-acetyl neuraminicsäure
NO975371L (no) Farmasöytisk sammensetning fremstilt ved tilföring av en smakstilsetningsbærer til et medikament
NO20003813L (no) FremgangsmÕter for Õ redusere eller forhindre smerte ved bruk av spicamycin eller derivater derav
KR890008156A (ko) 깅콜리드의 신규 알콜시 유도체, 그 제조 방법 및 이를 함유한 치료 조성물
NO962999D0 (no) Fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum, såvel som medikament inneholdende dem
NO996496L (no) (S) 2-metylamino-2-fenyl-n-butyl 3,4,5-trimetoksybenzoat samt anvendelse av denne ved behandling av kronisk smerte
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.